Results 81 to 90 of about 105,798 (208)

Environmental Drivers of Nontuberculous Mycobacteria in Tropical Freshwater Systems

open access: yesEnvironmental Microbiology, Volume 28, Issue 11, November 2026.
In tropical freshwater ecosystems, nontuberculous mycobacterial diversity and distribution is mainly driven by habitat and sample type, and local environmental factors such as sediment texture and depth. These findings highlight the importance of microhabitat conditions over broad biogeographic patterns in shaping mycobacterial communities.
Marine Combe   +8 more
wiley   +1 more source

Combined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective

open access: yesThe Clinical Respiratory Journal, Volume 20, Issue 11, November 2026.
This review summarizes recent advances in combined pulmonary fibrosis and emphysema (CPFE), proposing a novel etiologic classification framework encompassing four subtypes. We integrate a diagnostic algorithm to guide precise management and highlight emerging artificial intelligence strategies for risk stratification and dynamic prognostic assessment ...
Qinyu Deng   +5 more
wiley   +1 more source

Nerandomilast‐Associated Pneumonitis With a Positive Rechallenge: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 10, October 2026.
Nerandomilast was associated with new bilateral pulmonary opacities and inflammatory deterioration 9 days after treatment initiation in a woman with advanced interstitial lung disease. Withdrawal led to improvement, whereas reduced‐dose re‐exposure was followed by recurrence the next day and repeated improvement after discontinuation.
Toyoshi Yanagihara   +4 more
wiley   +1 more source

Coinfections With Respiratory Syncytial Virus in a Cohort of Adults With High‐Risk Conditions, 2015–2020: A Retrospective Observational Study

open access: yes
Health Science Reports, Volume 9, Issue 11, November 2026.
Oluwakemi D. Alonge   +7 more
wiley   +1 more source

Contemporary Concise Review 2025: Interstitial Lung Disease

open access: yesRespirology, Volume 31, Issue 10, Page 974-982, October 2026.
ABSTRACT Multidisciplinary discussion remains the cornerstone of ILD diagnosis and management, with recent advances further strengthening the integration of clinical, radiological, pathological, and molecular information. Updated ILD nomenclature and classification better align disease terminology with underlying morphology and pathobiology.
Tonia Magrì, Luca Richeldi
wiley   +1 more source

Aripiprazole-induced hypersensitivity pneumonitis.

open access: yes, 2017
Aripiprazole is an atypical antipsychotic agent commonly used in the management of schizophrenia. Aripiprazole has not been reported to have an association with interstitial lung disease.
Lone, Nazir   +3 more
core   +2 more sources

Efficacy and Safety of Immune Checkpoint Inhibitors for Lung Cancer Complicated by Interstitial Pneumonia: The CS‐Lung 003 Study, Branch Number 28

open access: yesThoracic Cancer, Volume 17, Issue 20, October 2026.
In the CS‐Lung003 trial, branch 28, which retrospectively investigated the efficacy and safety of ICIs in previously treated NSCLC complicated with IP, the median PFS was 5.8 months, and the median OS was 9.7 months. No significant difference was observed in PFS between patients with and without ICI‐related pneumonitis (6.8 vs. 3.3 months, respectively;
Kosuke Hamai   +14 more
wiley   +1 more source

Studies on the pathogenesis of hypersensitivity pneumonitis Part 1. Immunological and pathological examination of experimental animal model of hypersensitivity pneumonitis [PDF]

open access: yes, 1991
Hypersensitivity pneumonitis is well known as an allergic respiratory disease although the exact pathogenesis is still in controversy. An experimental animal model was established with Micropolyspora faeni (Mf) as the antigen, and the various ...
Makimoto, Koh
core  

Methotrexate-induced Hypersensitivity Pneumonitis appearing after 30 years of use: a case report

open access: yesJournal of Medical Case Reports, 2017
Background Methotrexate has been implicated in a variety of lung complications, one of which is hypersensitivity pneumonitis. Hypersensitivity pneumonitis most often occurs within the first year of starting low-dose orally administered methotrexate.
Mashal Salehi   +2 more
doaj   +1 more source

Role of antibodies and T cells in pigeon fanciers' lung [PDF]

open access: yes
: Introduction: Pigeon fanciers’ lung (PFL) is one of the most common forms of hypersensitivity pneumonitis (HP) in the UK. Generally it is considered that PFL is caused by immune complexes, however, this does not explain why some fanciers are ...
Nademi, Zohreh
core  

Home - About - Disclaimer - Privacy